JPH0923849A - Health food for quiet sleep - Google Patents
Health food for quiet sleepInfo
- Publication number
- JPH0923849A JPH0923849A JP7201677A JP20167795A JPH0923849A JP H0923849 A JPH0923849 A JP H0923849A JP 7201677 A JP7201677 A JP 7201677A JP 20167795 A JP20167795 A JP 20167795A JP H0923849 A JPH0923849 A JP H0923849A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- sleep
- calcium
- health food
- ginkgo biloba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000007958 sleep Effects 0.000 title claims abstract description 31
- 235000013402 health food Nutrition 0.000 title claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 30
- 239000011575 calcium Substances 0.000 claims abstract description 27
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 27
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 26
- 240000004371 Panax ginseng Species 0.000 claims abstract description 6
- 235000008434 ginseng Nutrition 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims description 18
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 18
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 18
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 18
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 18
- 235000020710 ginseng extract Nutrition 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 18
- 229940079593 drug Drugs 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 239000000463 material Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 206010001497 Agitation Diseases 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021033 Hypomenorrhoea Diseases 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 206010062519 Poor quality sleep Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000003326 hypnotic agent Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000012545 Psychophysiologic disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000001814 effect on stress Effects 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical group 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000008452 non REM sleep Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は安眠用健康食品に関
するものである。すなわち、不眠解消の医薬品ではな
く、飲食する事で夜の休息時の安眠が得られる所謂健康
食品である。TECHNICAL FIELD The present invention relates to a health food for sleep. That is, it is a so-called health food, which is not a medicine for eliminating insomnia, but is capable of obtaining a good night's sleep at rest by eating and drinking.
【０００２】[0002]
【従来の技術】近時、肉体的・精神的疲労を除去する目
的で、医薬品、食品、健康器具、寝具、浴剤等が販売さ
れている。医薬品は本来疾病時に用いられるものである
が、健康維持、疾病予防は日常の食生活が基本である。
従来、身体的疲労等を除去する直接的な方法は滋養強壮
剤あるいは疲労回復剤といわれる医薬品の服用である。
また、身体的疲労に伴う症状である不眠、肩コリ、倦怠
感、四肢の弱化などは夫々に対応する医薬品があるのが
現状である。2. Description of the Related Art Recently, pharmaceuticals, foods, health appliances, bedding, bath salts and the like have been sold for the purpose of eliminating physical and mental fatigue. Although medicines are originally used for illness, health maintenance and disease prevention are based on daily diet.
Conventionally, a direct method for removing physical fatigue is to take a medicine called a nutritional tonic or a fatigue recovery agent.
In addition, there are currently medicines that deal with insomnia, stiff shoulders, fatigue, weakening of limbs, which are symptoms associated with physical fatigue.
【０００３】そして、このような医薬品は本来医師、薬
剤師の指導によって服用すべきものである。[0003] Such medicines should be taken according to the guidance of doctors and pharmacists.
【０００４】[0004]
【発明が解決しようとする課題】特に不眠にあっては、
睡眠薬は医師の処方箋により投薬されるもので、病的な
不眠症にのみ用いられるものである。いわゆる寝つきが
悪い、睡眠が浅いといった病的でない場合の睡眠薬服用
は本質的な副作用の発現の危険性から好ましいものでは
ない。[Problems to be Solved by the Invention] Especially in sleeplessness,
Sleeping pills are given by a doctor's prescription and are used only for pathological insomnia. Taking so-called sleeping pills in so-called poor sleep and light sleep is not preferable because of the risk of the occurrence of essential side effects.
【０００５】医薬品としての睡眠薬は脳内の睡眠中枢に
直接作用するものが殆どである。しかるに、眠りを妨げ
る要因には、痛み、むくみ、お血、冷え、血糖値低下、
ストレス、栄養バランス（特にカルシウム不足）、血圧
異常、心不全、貧血、胃腸障害、排尿異常、体力低下、
自律神経失調など全身の機能に及んでいる。Most of the hypnotics as pharmaceuticals directly act on the sleep centers in the brain. However, factors that interfere with sleep include pain, swelling, blood, chills, decreased blood sugar levels,
Stress, nutritional balance (especially calcium deficiency), abnormal blood pressure, heart failure, anemia, gastrointestinal disorders, abnormal urination, decreased physical fitness,
It affects the functions of the whole body such as autonomic imbalance.
【０００６】不眠に悩む多くの人は上記複数の要因を持
っているのが一般的であり、睡眠中枢にのみ作用する医
薬品の服用はこれらの要因の改善にはつながらない。複
数の要因を改善するためには、夫々の要因に対応する複
数の医薬品を服用しなければならなくなり、さらに副作
用の危険度が増加すると考えられる。しかして、現在安
眠を得るための全身的に改善する所謂体調を整えるため
の食品はない。Many people suffering from insomnia generally have the above-mentioned factors, and taking a drug that acts only on the sleep center does not lead to improvement of these factors. In order to improve a plurality of factors, it is necessary to take a plurality of medicines corresponding to each factor, and it is considered that the risk of side effects increases. However, there is currently no food for improving the general condition for getting a good night's sleep.
【０００７】本発明は、上記の事実に鑑みて、できるだ
け多くの眠りを妨げる要因を改善するため、複合生薬を
主原料とした、安眠を確保するのに適した画期的な健康
食品を提供することを目的とする。[0007] In view of the above facts, the present invention provides an epoch-making health food containing a complex crude drug as a main ingredient and suitable for ensuring a good night's sleep in order to improve as many factors as possible to prevent sleep. The purpose is to do.
【０００８】[0008]
【課題を解決するための手段】本発明の安眠用健康食品
は、上記目的を達成するため、オタネニンジンエキス、
イチョウ葉エキス、霊芝エキスおよびカルシウムを構成
材料として所定の割合で混有してなることを特徴とす
る。Means for Solving the Problems The health food for sleep of the present invention has a ginseng extract,
It is characterized in that it contains a mixture of Ginkgo biloba extract, Ganoderma lucidum extract and calcium as constituent materials in a predetermined ratio.
【０００９】[0009]
【発明の実施の形態】以下、本発明の実施の形態につい
て詳細に説明する。Embodiments of the present invention will be described below in detail.
【００１０】人間の眠りを妨げる代表的な要因として
は、（１）身体の痛み、（２）冷え、（３）空腹感、
（４）精神疲労（ストレス蓄積）、（５）カルシウム、
ビタミンＢ１，Ｂ６，Ｂ１２の欠乏、（６）自律神経の
異常、（７）血圧異常（高血圧、低血圧）、（８）動
悸、不整脈、（９）貧血、（１０）胃もたれ、消化不良
等の胃腸障害、（１１）残尿、頻尿などの排尿不良、
（１２）便秘、（１３）体力消耗、全身倦怠感などがあ
る。したがって、本発明の実施の形態においては、この
様な安眠を妨げる要因を一つでも多く除去することので
きる効能を有する生薬材料およびイチョウ葉エキスを混
合して構成するものである。即ち、本実施の形態におけ
る安眠用健康食品は、オタネニンジンエキス、イチョウ
葉エキス、霊芝エキスおよびカルシウムを所定の割合で
混有するものである。以下、これらの各構成物について
詳細に説明する。Typical factors that prevent human sleep are (1) body pain, (2) coldness, (3) hunger,
(4) Mental fatigue (stress accumulation), (5) Calcium,
Vitamin B1, B6, B12 deficiency, (6) Autonomic nerve abnormality, (7) Blood pressure abnormality (hypertension, hypotension), (8) Palpitation, arrhythmia, (9) Anemia, (10) Stomach leaning, indigestion, etc. Gastrointestinal disorders, (11) poor urination such as residual urine, frequent urination,
(12) Constipation, (13) physical exhaustion, general malaise, etc. Therefore, in the embodiment of the present invention, a crude drug material having an effect of being able to remove even one of such factors that hinder the sleep and the ginkgo biloba extract are mixed. That is, the health food for sleep in the present embodiment contains ginseng extract, ginkgo biloba extract, ganoderma lucidum extract and calcium in a predetermined ratio. Hereinafter, each of these components will be described in detail.
【００１１】（Ａ）オタネニンジンエキス オタネニンジンは賦活、精神安定、老化防止等の作用が
あり、種々の症状に効き臨床利用の面で幅広い効果を持
つもので、「人参湯」や「補中益気湯」など多くの漢方
処方として用いられている。このニンジンエキスは不眠
に対して極めて高い効能があることが確認されるに至
り、数多くの文献にその研究成果が発表されている。例
えば、オタネニンジンエキスをラットに服用させると、
ノンレム睡眠が有意に増加し、睡眠障害の改善に効果が
あること、更に、中枢神経抑制作用、精神安定作用、コ
リン作動性作用、ヒスタミン様作用、血圧安定作用、鎮
静作用、自律神経失調症における心身症の予防・治療へ
の有効性等が存在することが確認されている。(A) Panax ginseng extract Panax ginseng has effects such as activation, mental stability, and anti-aging, and has a wide range of effects on various symptoms in terms of clinical use. It is used as a prescription for many Kampo medicines such as "yu." It has been confirmed that this carrot extract has an extremely high effect on insomnia, and the research results have been published in numerous documents. For example, when ginseng extract is taken in rats,
NREM sleep significantly increases and is effective in improving sleep disorders. In addition, in central nervous system depressant action, tranquilizing action, cholinergic action, histamine-like action, blood pressure stabilizing action, sedative action, autonomic imbalance. It has been confirmed that there is efficacy in the prevention and treatment of psychosomatic disorders.
【００１２】（Ｂ）イチョウ葉エキス イチョウ葉エキスは、海外で特にドイツやフランスでは
既に医薬として用いられ、医薬としての売上において常
にベスト５の位置を確保しており、人気の高い医薬原料
である。しかしながら、日本では薬事法の制限により医
薬品としては認可されておらず健康食品として用いられ
ているのが現状である。このイチョウ葉エキスの主成分
はフラボノイドであるが、イチョウ特有の構造である二
重フラボンが含まれている。イチョウ葉エキスの効能と
しては、毛細管壁を正常化（保護）するとともに血小板
凝集をコントロールし、血管を詰らせて梗塞の原因とな
る血栓の生成を防ぎ、血液の流れをスムースにする作用
を有している。これにより動脈硬化、高血圧、ストレ
ス、心臓病、脳卒中、痴呆など適用範囲が広いものとな
っている。さらに、このイチョウ葉エキスは不眠症にお
いても有意に改善が認められていることが数多くの医学
文献に発表されているところである。本発明において
は、この点に着目してイチョウ葉エキスを成分として加
えるものである。なお、イチョウ葉エキスは他の食品原
料と混合する際に全く禁忌作用はなく、副作用も全くな
いことが医学学術論文等で報告されている。(B) Ginkgo biloba extract Ginkgo biloba extract has already been used as a medicine overseas, especially in Germany and France, and has always been in the top 5 position in sales as a medicine, and it is a very popular medicinal raw material. . However, in Japan, it is not approved as a drug due to the restrictions of the Pharmaceutical Affairs Law and is used as a health food at present. The main component of this ginkgo biloba extract is flavonoid, but it contains double flavone, which is a structure unique to Ginkgo biloba. Ginkgo biloba extract has the effect of normalizing (protecting) the capillary wall, controlling platelet aggregation, preventing blood clots that clog blood vessels and causing infarction, and smooth the blood flow. Have This has broadened the range of applications such as arteriosclerosis, hypertension, stress, heart disease, stroke and dementia. Furthermore, it has been announced in numerous medical literatures that this ginkgo biloba extract has been found to be significantly improved in insomnia. In the present invention, paying attention to this point, ginkgo biloba extract is added as a component. It has been reported in medical academic papers that Ginkgo biloba extract has no contraindications when mixed with other food materials and has no side effects.
【００１３】（Ｃ）霊芝エキス 霊芝はサルノコシカケ科マンネンタケの子実体から得ら
れる生薬であり、漢方では強壮、補血、利水作用等のほ
かに精神安定作用があるほか、睡眠修飾効果があること
が認められている。すなわち、霊芝エキスをラットに投
与した場合には、明期においては総量変化の増加が認め
られないが、暗期ではノンレム睡眠の総量が有意に増加
することが認められ、また、レム睡眠総量は明期におい
ても有意な増加が認められている。このように、霊芝エ
キスには睡眠促進効果を与える成分が存在することが判
明している。これ故、本発明においては、霊芝エキスを
成分の一つとするものである。(C) Ganoderma lucidum extract Ganoderma lucidum is a crude drug obtained from the fruiting body of Ganoderma lucidum, Ganoderma lucidum, and has a tranquilizing effect in addition to tonicity, blood supply, water-use effect, etc. Is recognized. That is, when Ganoderma lucidum extract was administered to rats, there was no increase in the total amount change in the light period, but it was observed that the total amount of non-REM sleep increased significantly in the dark period. Is significantly increased even in the light period. As described above, it has been revealed that the Reishi extract has a component that has a sleep promoting effect. Therefore, in the present invention, Ganoderma lucidum extract is one of the components.
【００１４】（Ｄ）カルシウム カルシウムは骨格および歯牙の主成分として極めて重要
ばかりでなく、血中のカルシウム濃度が低下すると、神
経の興奮性が異常に高まることが医学上明らかにされて
おり、この神経の興奮性が睡眠を妨げるものとなってい
る。したがって、本発明においては、神経の興奮性を抑
制させるものとしてカルシウムを成分の一つとするもの
である。なお、このカルシウムとしては、真珠カルシウ
ム、卵殻カルシウム、骨粉カルシウム、カキ殻カルシウ
ム、燐酸カルシウムを始め多くの種類があるが、本発明
においては、特に限定されるものではなく、いずれの種
類のカルシウムであっても良いが、カルシウムは吸収性
に問題があるので本実施の形態においては、吸収効率の
優れた真珠カルシウムを用いるものである。(D) Calcium Not only is calcium very important as a main component of the skeleton and teeth, but it has been medically clarified that the excitability of nerves is abnormally increased when the calcium concentration in blood is lowered. Nervous excitability interferes with sleep. Therefore, in the present invention, calcium is one of the components for suppressing nerve excitability. As this calcium, there are many kinds including pearl calcium, egg shell calcium, bone meal calcium, oyster shell calcium, and calcium phosphate, but in the present invention, it is not particularly limited and any kind of calcium can be used. Although it may be present, since calcium has a problem in absorbability, pearl calcium having excellent absorption efficiency is used in the present embodiment.
【００１５】本発明の実施の形態においては、オタネニ
ンジンエキス１重量部に対し、イチョウ葉エキスを０．
５〜１．０重量部、霊芝エキスを０．１〜０．５重量
部、カルシウムを０．１〜１．０重量部の割合で混合し
たもの。またそれを乾燥粉末にしたもの。それにシロッ
プまたは蜂蜜を加え濃縮液のもの。前記粉末状のものに
賦形剤を加えて型込め凝固させて顆粒状、錠剤状に形成
したもの。更に、そのエキス状、粉末状、顆粒状のもの
をカプセルに封入したもの等形態において需要者の利用
に便ならしめることが可能である。In the embodiment of the present invention, ginkgo biloba extract is added to 1 part by weight of ginseng extract.
5 to 1.0 parts by weight, Ganoderma lucidum extract in an amount of 0.1 to 0.5 parts by weight, and calcium in an amount of 0.1 to 1.0 parts by weight. Also, it is a dry powder. Concentrated liquid with syrup or honey added to it. Excipients are added to the above powder and the mixture is molded and solidified to form granules or tablets. Furthermore, it is possible to make it convenient for the users in the form of the extract, powder, or granules encapsulated.
【００１６】次に、好ましい１日当りの摂取量の一例に
ついて説明すると、オタネニンジンエキスは２００ミリ
グラム、イチョウ葉エキスは１５０ミリグラム、霊芝エ
キスは５０ミリグラム、カルシウムは１００ミリグラム
である。もっとも、これは標準的なものであって、これ
に限定されるべき性質のものではないことはいうまでも
ない。Next, an example of a preferable daily intake will be explained. The ginseng extract is 200 mg, the ginkgo biloba extract is 150 mg, the ganoderma lucidum extract is 50 mg, and the calcium is 100 mg. However, it goes without saying that this is a standard one and is not of a nature that should be limited thereto.
【００１７】本発明においては、図１に示すように、構
成材料であるオタネニンジン、イチョウ葉、霊芝から各
エキス分を抽出する。そして、混合工程において抽出さ
れた各エキスとカルシウムを混合するものである。また
前記各構成材料を乾燥粉末としそれを混合した状態でそ
の混合エキスを抽出しカルシウムと混合する事でも同様
のものが得られるものである。抽出方法においては公知
の方法を用いて行う。そしてこの後最終製品の形態に合
せた加工を行う。In the present invention, as shown in FIG. 1, each extract is extracted from the constituent materials ginseng, ginkgo biloba, and ganoderma lucidum. Then, each extract extracted in the mixing step is mixed with calcium. The same thing can be obtained by making each of the constituent materials into a dry powder and extracting the mixed extract in a mixed state and mixing with calcium. A known method is used for the extraction method. Then, after this, processing is performed according to the form of the final product.
【００１８】すなわち、本発明の安眠用健康食品をその
ままエキス状として提供する場合には、この混合エキス
をビン詰めする。またエキス状のものにシロップや蜂蜜
を混合して濃縮液としてビン詰めする。粉末状にして提
供する場合には、例えば、乾燥粉末状として袋詰めすれ
ばよい。また、顆粒或は錠剤にして提供する場合には、
これらの粉末状とした後に賦形剤としての乳糖等を添加
した後に型込め凝固させる。更に、ハードカプセルとし
てゼラチンカプセル或はソフトカプセルとしてゼラチン
をベースに可塑剤としてグリセリン、水等を加えたカプ
セルに混合エキス、乾燥粉末、顆粒を封入すれば、極め
て飲みやすいカプセルタイプの食品となる。That is, when the health food for sleep of the present invention is provided as an extract as it is, the mixed extract is bottled. Also, syrup or honey is mixed with the extract and bottled as a concentrated liquid. When it is provided in the form of powder, it may be packed in the form of dry powder, for example. Also, when providing in the form of granules or tablets,
After powdering these, lactose and the like as an excipient is added, and then the mixture is molded and solidified. Furthermore, by encapsulating the mixed extract, dry powder, and granules in a gelatin capsule as a hard capsule or a gelatin capsule as a soft capsule, to which glycerin, water and the like are added as a plasticizer, a capsule type food product is obtained which is extremely easy to drink.
【００１９】[0019]
【発明の効果】上記したように、本発明の安眠用健康食
品によれば、オタネニンジンエキス、イチョウ葉エキ
ス、霊芝エキスおよびカルシウムを含有することから、
前記各構成材料の効能が相乗的に作用し、脳神経の興奮
性を抑制し、精神を安定させるとともに、血液の流れを
スムースにして不眠の一因となるストレスに対する効果
があり、体調を整えることとなり安眠を得ることができ
る。しかして、本発明は、従来の医薬品としての睡眠薬
ではなく、食品として飲食して直ちに睡魔におそわれ、
動作の弛緩に陥るものではなく、飲食することで体調を
整えて夜の休息時においての安眠が得られるものである
から、所謂睡眠薬的な薬効は生じないものである。でき
るだけ多くの眠りを妨げる要因を改善するため、複合的
に生薬を主原料として、安眠を確保するのに適した画期
的な健康食品を提供したものである。As described above, according to the health food for sleep of the present invention, since it contains ginseng extract, ginkgo biloba extract, ganoderma lucidum extract and calcium,
The effects of the above-mentioned constituent materials act synergistically to suppress excitability of cranial nerves, stabilize the mind, and have an effect on stress that contributes to insomnia by smoothing blood flow and adjusting physical condition. You can get a good night's sleep. Thus, the present invention is not a sleeping pill as a conventional medicine, but is eaten and eaten as a food and immediately anxious about drowsiness,
It does not cause relaxation of movements, and it is possible to obtain a good night's sleep by resting at night by eating and drinking, so that the so-called hypnotic drug effect does not occur. In order to improve as many factors that interfere with sleep as possible, it provides a revolutionary health food suitable for ensuring a good night's sleep by using crude drug as a main ingredient in combination.
【図１】本発明の製造工程の概略を示す説明図である。FIG. 1 is an explanatory view showing an outline of a manufacturing process of the present invention.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 ＦＩ 技術表示箇所 Ａ６１Ｋ 35/84 Ａ６１Ｋ 35/84 Ａ ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display area A61K 35/84 A61K 35/84 A
Claims (5)
ス、霊芝エキスおよびカルシウムが所定の割合で混有さ
れていることを特徴とする安眠用健康食品。1. A health food for sleep, characterized in that ginseng extract, ginkgo biloba extract, ganoderma lucidum extract and calcium are mixed in a predetermined ratio.
イチョウ葉エキスが０．５〜１．０重量部、霊芝エキス
が０．１〜０．５重量部、カルシウムが０．１〜１．０
重量部の割合で混有されていることを特徴とする請求項
１に記載の安眠用健康食品。2. To 1 part by weight of Panax ginseng extract,
Ginkgo biloba extract 0.5-1.0 parts by weight, Reishi extract 0.1-0.5 parts by weight, calcium 0.1-1.0
The health food for sleep according to claim 1, wherein the health food for sleep is mixed in a ratio of parts by weight.
ス、霊芝エキスおよびカルシウムが所定の割合で混有さ
れており、これに賦形剤が添加されて顆粒状または錠剤
状に形成されていることを特徴とする請求項１および請
求項２に記載の安眠用健康食品。3. A ginseng extract, ginkgo biloba extract, ganoderma lucidum extract and calcium are mixed in a predetermined ratio, and an excipient is added to the mixture to form granules or tablets. The health food for sleep according to claim 1 or 2.
ス、霊芝エキスおよびカルシウムが所定の割合で混有さ
れているものにシロップまたは蜂蜜を加え濃縮液に形成
されていることを特徴とする請求項１および請求項２に
記載の安眠用健康食品。4. A ginseng extract, ginkgo biloba extract, ganoderma lucidum extract and calcium mixed in a predetermined ratio with syrup or honey to form a concentrated solution. The health food for sleep according to claim 2.
ス、霊芝エキスおよびカルシウムが所定の割合で混有さ
れているもの、それを乾燥末状にしたもの或は顆粒状の
ものをカプセルに封入して形成されていることを特徴と
する請求項１、請求項２および請求項３に記載の安眠用
健康食品。5. A mixture of ginseng extract, ginkgo biloba extract, ganoderma lucidum extract and calcium in a predetermined ratio, dried powder or granules encapsulated in a capsule. The health food for sleep as claimed in claim 1, claim 2 or claim 3, which is characterized in that
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7201677A JPH0923849A (en) | 1995-07-14 | 1995-07-14 | Health food for quiet sleep |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7201677A JPH0923849A (en) | 1995-07-14 | 1995-07-14 | Health food for quiet sleep |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0923849A true JPH0923849A (en) | 1997-01-28 |
Family
ID=16445075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7201677A Pending JPH0923849A (en) | 1995-07-14 | 1995-07-14 | Health food for quiet sleep |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0923849A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000054791A1 (en) * | 1999-03-16 | 2000-09-21 | Medichemie Ag | Use of extracts from ginkgo biloba leaves for treating sleep disorders |
| JP2006158351A (en) * | 2004-12-10 | 2006-06-22 | Atsuyoshi Murakami | Health supplements |
| CN103720765A (en) * | 2014-01-16 | 2014-04-16 | 珠海海滨医药生物科技有限公司 | Traditional Chinese medicine composition for treating diabetes and preparation method thereof |
| CN103735713A (en) * | 2013-12-30 | 2014-04-23 | 广西梧州制药（集团）股份有限公司 | Chinese medicinal composition for improving nutritional anemia and preparation method thereof |
| CN103784589A (en) * | 2014-02-13 | 2014-05-14 | 徐艳艳 | Compound medicine for preventing and treating hemophilia |
| CN103800463A (en) * | 2014-02-18 | 2014-05-21 | 河南中医学院 | Traditional Chinese medicine granules for treating insomnia |
| JP2018104397A (en) * | 2016-12-28 | 2018-07-05 | 国立大学法人九州大学 | Anti-mental exhaustion agent, food (health supplement) and bittering agent using this anti-mental exhaustion agent, and production methods thereof |
| JP2021073952A (en) * | 2019-11-13 | 2021-05-20 | 株式会社Ａｔｕｍｉｓｔ | Food product |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6388126A (en) * | 1986-10-01 | 1988-04-19 | Toyo Yakushiyoku Kogyo Kk | Inhibitor of exciting action by caffeine |
| JPH01242533A (en) * | 1988-03-25 | 1989-09-27 | Lotte Co Ltd | Tranquilizing food and drink |
| JPH01313435A (en) * | 1988-05-16 | 1989-12-18 | Young S Kim | Gyuoseishin liquid and its production |
| JPH03103143A (en) * | 1989-09-18 | 1991-04-30 | Yoshio Tanaka | Chlorella-containing oil and fat food and preparation thereof |
| JPH05271083A (en) * | 1992-03-25 | 1993-10-19 | Daicel Chem Ind Ltd | CNS drugs |
| JPH06339347A (en) * | 1991-03-09 | 1994-12-13 | Ayako Tsuneto | Chinese meal jelly series |
| JPH07502522A (en) * | 1991-12-23 | 1995-03-16 | ドクター・ビィルマール・シュバーベ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・カンパニー | Pharmaceutical preparations containing bilobalide for the treatment of tension and anxiety |
-
1995
- 1995-07-14 JP JP7201677A patent/JPH0923849A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6388126A (en) * | 1986-10-01 | 1988-04-19 | Toyo Yakushiyoku Kogyo Kk | Inhibitor of exciting action by caffeine |
| JPH01242533A (en) * | 1988-03-25 | 1989-09-27 | Lotte Co Ltd | Tranquilizing food and drink |
| JPH01313435A (en) * | 1988-05-16 | 1989-12-18 | Young S Kim | Gyuoseishin liquid and its production |
| JPH03103143A (en) * | 1989-09-18 | 1991-04-30 | Yoshio Tanaka | Chlorella-containing oil and fat food and preparation thereof |
| JPH06339347A (en) * | 1991-03-09 | 1994-12-13 | Ayako Tsuneto | Chinese meal jelly series |
| JPH07502522A (en) * | 1991-12-23 | 1995-03-16 | ドクター・ビィルマール・シュバーベ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・カンパニー | Pharmaceutical preparations containing bilobalide for the treatment of tension and anxiety |
| JPH05271083A (en) * | 1992-03-25 | 1993-10-19 | Daicel Chem Ind Ltd | CNS drugs |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000054791A1 (en) * | 1999-03-16 | 2000-09-21 | Medichemie Ag | Use of extracts from ginkgo biloba leaves for treating sleep disorders |
| CH693498A5 (en) * | 1999-03-16 | 2003-09-15 | Medichemie Ag | Use of extracts of Ginkgo biloba leaves to treat sleep disorders. |
| JP2006158351A (en) * | 2004-12-10 | 2006-06-22 | Atsuyoshi Murakami | Health supplements |
| CN103735713A (en) * | 2013-12-30 | 2014-04-23 | 广西梧州制药（集团）股份有限公司 | Chinese medicinal composition for improving nutritional anemia and preparation method thereof |
| CN103720765A (en) * | 2014-01-16 | 2014-04-16 | 珠海海滨医药生物科技有限公司 | Traditional Chinese medicine composition for treating diabetes and preparation method thereof |
| CN103784589A (en) * | 2014-02-13 | 2014-05-14 | 徐艳艳 | Compound medicine for preventing and treating hemophilia |
| CN103800463A (en) * | 2014-02-18 | 2014-05-21 | 河南中医学院 | Traditional Chinese medicine granules for treating insomnia |
| JP2018104397A (en) * | 2016-12-28 | 2018-07-05 | 国立大学法人九州大学 | Anti-mental exhaustion agent, food (health supplement) and bittering agent using this anti-mental exhaustion agent, and production methods thereof |
| JP2021073952A (en) * | 2019-11-13 | 2021-05-20 | 株式会社Ａｔｕｍｉｓｔ | Food product |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lambert et al. | Potential interaction between warfarin and boldo‐fenugreek | |
| KR20030031902A (en) | Tryptophan source from plants and uses therefor | |
| JPH0923851A (en) | Health food for quiet sleep | |
| WO2013013498A1 (en) | Chinese medicine beverage for nourishing the heart to calm the mind | |
| CN106728261A (en) | A kind of pharmaceutical composition for treating insomnia | |
| CN105901145A (en) | Sleep comforting pasteurized milk and preparation method thereof | |
| CN108783458A (en) | Promote the compound ganoderma health food of sleep pleasure mood prevention of depression | |
| US20040185118A1 (en) | Health food for good sleep | |
| JP3343708B2 (en) | Healthy food for sleep | |
| CN1052888C (en) | Preparation for sobering up and preventing drunkenness and preparing method thereof | |
| CN103908539B (en) | Traditional Chinese medicine composition for treating hypertension as well as preparation method and application of traditional Chinese medicine composition | |
| CN106474356A (en) | A kind of medicine of logical stalkization bolt and preparation method thereof | |
| CN111135249A (en) | Medicinal and edible traditional Chinese medicine composition for regulating and improving insomnia and preparation method thereof | |
| CN101991829B (en) | Medicament for treating stomach illness | |
| CN107050163A (en) | With Chinese medicine composition, preparation for improving sleep quality effect and preparation method thereof | |
| CN106692667A (en) | Composition with effects of reducing blood pressure, blood fat and blood glucose and use of composition | |
| RU2188564C2 (en) | Biologically active additive to food for prophylaxis and reduction of weather dependence and sensitivity to sun and geomagnetic storms | |
| CN105616581A (en) | Glipizide-containing pharmaceutical composition for treating diabetes and preparation method thereof | |
| CN105833043A (en) | Application of traditional Chinese medicine composition in preparation of medicine for treating primary hypertension | |
| JP2000157207A (en) | Functional food | |
| CN101156690A (en) | Sleep-regulating and anti-senile nutrition health products and method for making same | |
| CN113521184A (en) | A composition for improving sleep quality | |
| CN1256110C (en) | Chinese medicine for expelling stasis | |
| CN106620485A (en) | Preparation method of oral digestion-promoting medicated leaven composition | |
| CN108261511A (en) | A kind of composition with antiobesity action and preparation method thereof and purposes |